Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Ivana Djuretic"'
Autor:
Naveen Sharma, James Allison, Andres Salazar, Hussein Sultan, Ton Schumacher, Ivana Djuretic, Yik Andy Yeung, Jeffrey Ward, Marco Colonna, Yuang Song, Samuel Ameh, Robert Schreiber, Kenneth Murphy, Yoshiko Takeuchi, Corazon Arthur, Kathleen Sheehan, Kelly D Moynihan, Vladimir Sukhov, Maria Firulyova, Tian-Tian Liu, Maxim Artyomov
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/644e4169fe854128912cee96e977b9ca
Autor:
Ivana Djuretic, Yik Andy Yeung, Renee Greer, Arisa Paul, Jeffrey Houser, Audrey Hollingsworth, Wei Wei Prior, Manu Kumar, Ruth Lan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/2703b245d0a1409e93b1a79ae8c08c7c
Autor:
Hussein Sultan, Ton Schumacher, Ivana Djuretic, Yik Andy Yeung, Kelly Moynihan, Yuang Song, Samuel Ameh, Robert Schreiber
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/5d313949bf71463da1efa7384d3389b3
Autor:
Wei Chen, Ton Schumacher, Ivana Djuretic, Irene Ni, Paul Bessette, Kelly Moynihan, Danielle Pappas, Terrence Park, Mike Chin, Andy Yeung
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/3f99a2c2e490492d8622bf7c6de9d877
Autor:
Renee Greer, Henry Nguyen, Paul Mesko, Ruth Lan, Wei Wei Prior, Hussein Sultan, Meghana Sukthankar, Irene Ni, S Michael Chin, Kelly Moynihan, Ton Schumacher, Robert Schreiber, Andy Yeung, Ivana Djuretic
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Kelly Moynihan, Danielle Pappas, Hussein Sultan, Terrence Park, Manu Kumar, Ruth Lan, Irene Ni, Jessie Chen, Michael Chin, Ton Schumacher, Andy Yeung, Robert Schreiber, Ivana Djuretic
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Ivana Djuretic, Dave Tsao, Yuanming Xu, Lucia Campos Carrascosa, Gabriel R. Starbeck-Miller, Valeska de Ruiter, Wenjing Yang, Javier Chaparro-Riggers, Zhouhong Ge, Changhua Ji, Tina Mistry, Jaap Kwekkeboom, Lidia Mosyak, John Zeytounian, Matthew Ling-Hon Chu, Renny Feldman, Lisanne Noordam, Eugenia Kraynov, Tzu-Hsuan Huang, Martin E. van Royen, Diamanda Rigas, Sherman M. Chin, Irene Ni, Dave Sprengers, Shih-Hsun Chen, Danielle Pappas, Kevin Lindquist, Michael Doukas, Patrick P.C. Boor, Joanne Verheij, Keith A. Ching, Magdalena Dorywalska, Luz Marina Londono, Joris I. Erdmann, Dirk J. Grünhagen, Laura Lin, Bing Kuang, Jan N. M. IJzermans, Yik Andy Yeung, James Patterson, Jie Guo, Salah Mahmoudi, Terrence Park, Pascal G. Doornebosch, Robert C Rickert
Publikováno v:
Cancer Immunology Research, 9(10), 1141-1157. American Association for Cancer Research Inc.
Cancer immunology research, 9(10), 1141-1157. American Association for Cancer Research Inc.
Cancer immunology research, 9(10), 1141-1157. American Association for Cancer Research Inc.
The use of cytokines for immunotherapy shows clinical efficacy but is frequently accompanied by severe adverse events caused by excessive and systemic immune activation. Here, we set out to address these challenges by engineering a fusion protein of
Autor:
Sara Sleiman, Nathan D Mathewson, Feng Shen, Kelly Moynihan, Wei Chen, Paul Bessette, Chris Kimberlin, Danielle Pappas, Terrence Park, Andy Yeung, Ivana Djuretic, Saar Gill
Publikováno v:
Blood. 140:10259-10260
Autor:
Renee Greer, David Liu, Henry Nguyen, Ruth Lan, Wei Wei Prior, Meghana Sukthankar, Paul Mesko, irene Ni, Mike Chin, Kelly Moynihan, Ton Schumacher, Ivana Djuretic, Andy Yeung
Publikováno v:
Cancer Research. 82:2882-2882
Interleukin-21 (IL-21) is a pleiotropic cytokine that activates multiple lymphoid and myeloid immune cell subsets. IL-21 can have beneficial effects on anti-tumor immune responses due to its ability to activate STAT3 in CD8+ T cells and promote cytot
Autor:
Kelly D. Moynihan, Danielle Pappas, Terrence Park, Wei Chen, Irene Ni, Paul Bessette, Henry Nguyen, David Liu, Mike Chin, Ruth Lan, Aaron Arvey, Ton N. Schumacher, Yik Andy Yeung, Ivana Djuretic
Publikováno v:
Cancer Research. 82:3518-3518
High dose IL-2 was the first modern immunotherapy to show complete responses in a subset of cancer patients. The liabilities of IL-2 prompted development of second-generation molecules, which signal through the IL-2Rβγ (“not-α” IL-2 and IL-15